- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06683183
Ability of the Polar Wearables to Detect Fetal Heart Rate - Pilot Clinical Study
The aim of this clinical pilot study is
- to evaluate the ability of the wearables to detect fetal heart rate
- to evaluate the ability to distinguish the fetal ECG from the ECG of the mother
The participating pregnant women will wear the Polar wearables (chest band, smart watch, arm band) for 15 minutes during of which, the data will be collected with all three wearables and patient monitor (reference device). The data from the wearables will be compared with the patient monitor data referred as golden standard. Background information will be collected with questionnaires from the participants. The data collection will be conducted in hospital environment.
Study Overview
Status
Conditions
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Turku, Finland
- Turku University Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- duration of pregnancy at least 29+0 weeks
- single pregnancy
- age at least 18 years
- ability to participate in Finnish. No exclusion criteria
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
|---|
|
Pregnant women
Pregnant women will wear the set of wearables (chest band, smart watch and arm band) for 15 minutes.
In addition, pregnant woman's ECG and fetal heart rate will be measured with hospital's patient monitor.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Fetal heart rate
Time Frame: 15 minute data collection
|
15 minute data collection
|
Collaborators and Investigators
Sponsor
Collaborators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- VARHA/12937/13.02.02/2024
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Fetal Heart Rate Tracing
-
Cairo UniversityCompletedUmbilical Artery Doppler | Fetal Heart Rate TracingEgypt
-
Central Hospital, Nancy, FranceCompleted
-
Halic UniversityNot yet recruitingStress | Cortisol; Hypersecretion | Fetal Heart Rate Disorder
-
University of ManchesterCompletedFetal Distress | Fetal Heart Rate Disorder NosUnited Kingdom
-
The Chaim Sheba Medical CenterNot yet recruitingFetal Heart Rate Abnormalities | Labor Epidural Analgesia | Maternal Hypotension
-
Hospices Civils de LyonTerminatedFetal Heart Rate Variability
-
Mindchild Medical Inc.Completed
-
Unyime ItukRecruitingFetal Heart Rate or Rhythm Abnormality Affecting Fetus | Fetal Bradycardia Complicating Labor and Delivery | Fetal Bradycardia During LaborUnited States
-
University of AlbertaCompletedPregnancy Related | Glucose, Low Blood | Fetal Heart Rate or Rhythm Abnormality Affecting Fetus | Fetal Blood FlowCanada